FindTrial
Sign In

Study on the Benefits of Hemodiafiltration Compared to Hemodialysis in Terms of Mortality and Cardiovascular Events

Study on the Benefits of Hemodiafiltration Compared to Hemodialysis in Terms of Mortality and Cardiovascular Events

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085210
Enrollment
Unknown
Registered
2024-06-03
Start date
2024-06-04
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease, Hemodialysis

Interventions

HD group (Hemodialysis):None
HDF group (Hemodiafiltration):None

Sponsors

Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Chronic kidney disease stage 5 patients on maintenance hemodialysis from the Huashan Hospital from October 2013 to December 2023.(dialysis time >= 3 months); 2. Age = 18 years

Exclusion criteria

Exclusion criteria: 1. Absence of certain baseline covariates, such as age, sex and blood pressure. 2. Any other circumstance in which the researcher believes that the subject cannot be enrolled in the trial.

Design outcomes

Primary

MeasureTime frame
All-cause mortality;Cardiovascular mortality;Hemorrhagic events;Fistula or catheter related events;—

Secondary

MeasureTime frame
Cardiovascular events;Infection-related events;Tumor-related events;—

Countries

China

Contacts

Public ContactMengjing Wang,Chen Jing

Huashan Hospital Affiliated to Fudan University

fiyona27@126.com+86 137 6467 6029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026